Rapid Discontinuation of Steroids in Living Donor Kidney Transplantation: A Pilot Study
暂无分享,去创建一个
D. Dunn | A. Matas | J. Najarian | R. Kandaswamy | D. Sutherland | S. Paraskevas | R. Gruessner | A. Humar | W. Payne | K. Gillingham | R. Gruessner | T. Ramcharan | J. Gillingham | John S. Najarian | D. E. Sutherland | D. L. Dunn | D. Dunn | J. Najarian
[1] D. Dunn,et al. 2,500 Living Donor Kidney Transplants: A Single-Center Experience , 2001, Annals of surgery.
[2] F. Oppenheimer,et al. Double-blind comparison of two corticosteroid regimens plus mycophenolate mofetil and cyclosporine for prevention of acute renal allograft rejection. , 2000, Transplantation.
[3] T A Louis,et al. A meta-analysis of immunosuppression withdrawal trials in renal transplantation. , 2000, Journal of the American Society of Nephrology : JASN.
[4] W. Blackwelder,et al. Decreased bone mineral density during low dose glucocorticoid administration in a randomized, placebo controlled trial. , 2000, The Journal of rheumatology.
[5] J. Soulillou,et al. Low incidence of kidney rejection after simultaneous kidney-pancreas transplantation after antithymocyte globulin induction and in the absence of corticosteroids: results of a prospective pilot study in 28 consecutive cases. , 2000, Transplantation.
[6] A. Monaco,et al. RAPID STEROID WITHDRAWAL VERSUS STANDARD STEROID TREATMENT IN PATIENTS TREATED WITH SIMULECT®, NEORAL®, AND CELLCEPT® FOR THE PREVENTION OF ACUTE REJECTION IN RENAL TRANSPLANTATION: A MULTICENTER, RANDOMIZED TRIAL.: Abstract# 83 , 2000 .
[7] S. Kulkarni,et al. EARLY CORTICOSTEROID CESSATION AT ONE WEEK FOLLOWING KIDNEY TRANSPLANT UNDER TACROLIMUS AND MYCOPHENOLATE MOFETIL (MMF) IMMUNOSUPPRESION, THREE‐YEAR FOLLOW‐UP.: Abstract# 88 , 2000 .
[8] D. Kaufman,et al. KIDNEY TRANSPLANTATION WITHOUT PREDNISONE.: Abstract# 85 , 2000 .
[9] B. Kiberd,et al. RENAL TRANSPLANTATION WITHOUT STEROIDS ‐ ONE YEAR RESULTS OF A MULTICENTRE CANADIAN PILOT STUDY.: Abstract# 86 , 2000 .
[10] D. Stablein,et al. Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil--a prospective randomized study. Steroid Withdrawal Study Group. , 1999, Transplantation.
[11] M. Rieder,et al. Pretreatment with Glucocorticoids Enhances T-Cell Effector Function: Possible Implication for Immune Rebound Accompanying Glucocorticoid Withdrawal , 1999, Cell transplantation.
[12] R. Kandaswamy,et al. OPTIMAL TIMING FOR A PANCREAS TRANSPLANT AFTER A SUCCESSFUL KIDNEY TRANSPLANT , 1999, Transplantation.
[13] S. Birkeland. Steroid-free immunosuppression after kidney transplantation with antithymocyte globulin induction and cyclosporine and mycophenolate mofetil maintenance therapy. , 1998, Transplantation.
[14] A. Matas. Risk factors for chronic rejection--a clinical perspective. , 1998, Transplant immunology.
[15] A. Matas,et al. Effect of early cyclosporine levels on kidney allograft rejection. , 1997, Clinical transplantation.
[16] D. Hricik,et al. Determinants of long-term allograft function following steroid withdrawal in renal transplant recipients. , 1995, Clinical transplantation.
[17] A. Matas,et al. Delayed graft function, acute rejection, and outcome after cadaver renal transplantation. The multivariate analysis. , 1995, Transplantation.
[18] D. Hricik,et al. Steroid-free immunosuppression in cyclosporine-treated renal transplant recipients: a meta-analysis. , 1993, Journal of the American Society of Nephrology : JASN.
[19] Sinclair Nr. Low-dose steroid therapy in cyclosporine-treated renal transplant recipients with well-functioning grafts. The Canadian Multicentre Transplant Study Group. , 1992 .
[20] B. Julian,et al. Rapid loss of vertebral mineral density after renal transplantation. , 1991, The New England journal of medicine.
[21] T. Starzl,et al. THE REVERSAL OF REJECTION IN HUMAN RENAL HOMOGRAFTS WITH SUBSEQUENT DEVELOPMENT OF HOMOGRAFT TOLERANCE. , 1963, Surgery, gynecology & obstetrics.
[22] D. Dunn,et al. 2,500 Living donor kidney transplants , 2001 .
[23] N. L. Johnson,et al. Multivariate Analysis , 1958, Nature.